Novartis Aktie
110,50
EUR
+1,60
EUR
+1,47
%
102,88
CHF
+2,46
CHF
+2,45
%
Werbung
Novartis Aktie Analyse
| 03.07.13 | Novartis kaufen | Citigroup Corp. | |
| 07.06.13 | Novartis kaufen | Jefferies & Company Inc. | |
| 28.05.13 | Novartis kaufen | Exane-BNP Paribas SA | |
| 28.05.13 | Novartis kaufen | Jefferies & Company Inc. | |
| 23.05.13 | Novartis kaufen | Société Générale Group S.A. (SG) | |
| 15.05.13 | Novartis kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.05.13 | Novartis kaufen | Citigroup Corp. | |
| 25.04.13 | Novartis kaufen | UBS AG | |
|
Werbung
|
|||
| 17.04.13 | Novartis kaufen | UBS AG | |
| 27.03.13 | Novartis kaufen | UBS AG | |
| 01.03.13 | Novartis kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.02.13 | Novartis kaufen | Société Générale Group S.A. (SG) | |
| 06.02.13 | Novartis kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.13 | Novartis kaufen | UBS AG | |
| 29.01.13 | Novartis kaufen | Jefferies & Company Inc. | |
| 24.01.13 | Novartis Kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.12.12 | Novartis outperform | Credit Suisse Group | |
| 30.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 27.11.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 20.11.12 | Novartis buy | Sarasin Research | |
| 16.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 15.11.12 | Novartis buy | UBS AG | |
| 15.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 12.11.12 | Novartis outperform | Credit Suisse Group | |
| 08.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 02.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 30.10.12 | Novartis buy | Deutsche Bank AG | |
| 29.10.12 | Novartis outperform | Credit Suisse Group | |
| 26.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 25.10.12 | Novartis buy | Sarasin Research | |
| 24.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.10.12 | Novartis buy | Nomura | |
| 19.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 17.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 16.10.12 | Novartis outperform | Credit Suisse Group | |
| 12.10.12 | Novartis outperform | Credit Suisse Group | |
| 12.10.12 | Novartis buy | Nomura | |
| 12.10.12 | Novartis buy | UBS AG | |
| 11.10.12 | Novartis buy | Deutsche Bank AG | |
| 11.10.12 | Novartis buy | UBS AG | |
| 04.10.12 | Novartis buy | Nomura | |
| 01.10.12 | Novartis buy | Sarasin Research | |
| 24.09.12 | Novartis buy | Sarasin Research | |
| 11.09.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 03.09.12 | Novartis kaufen | Die Actien-Börse | |
| 31.08.12 | Novartis buy | Deutsche Bank AG | |
| 31.08.12 | Novartis buy | Sarasin Research | |
| 28.08.12 | Novartis buy | Deutsche Bank AG | |
Werbung
Werbung